Demyelinating diseases are typical responses of the white matter of the central nervous system to detrimental factors such as infection, poisoning, degeneration and malnutrition. Of them, inflammatory demyelinating diseases including multiple sclerosis and acute disseminated encephalomyelitis are most commonly found. The current paper discusses the pathomechanism of inflammatory demyelinating diseases and experimental as well as clinical possibilities of olfactory ensheathing cells (OECS) for their treatment, and compares OECS with Schwann cells and oligodendroglias in clinical use. Renewed research efforts are required to investigate the molecular biology of OECS regarding the existing disadvantages of OECS transplant.
Key words: Demyelinating diseases, nerve regeneration, functional recovery
Copyright © 2020 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0